Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 75,627 | 24,897 | 23,187 | 18,563 | 22,755 |
| Marketable Securities | 106,750 | 59,065 | 54,428 | 60,109 | 69,374 |
| Receivables | 104 | 44 | 32 | 61 | 140 |
| TOTAL | $184,453 | $85,114 | $78,810 | $80,398 | $94,236 |
| Non-Current Assets | |||||
| PPE Net | 7,131 | 7,205 | 7,566 | 7,998 | 8,447 |
| Intangibles | 32,545 | 32,798 | 33,052 | 33,305 | 33,597 |
| Other Non-Current Assets | 236 | 424 | 409 | 428 | 460 |
| TOTAL | $39,912 | $40,427 | $41,027 | $41,731 | $42,504 |
| Total Assets | $224,365 | $125,541 | $119,837 | $122,129 | $136,740 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,630 | 5,592 | 5,693 | 5,629 | 5,294 |
| Accounts payable and accrued liabilities | 2,451 | 745 | 1,281 | 395 | 535 |
| Accrued Expenses | 9,692 | 10,960 | 8,157 | 6,555 | 6,359 |
| Other current liabilities | 557 | 388 | N/A | N/A | 358 |
| TOTAL | $18,330 | $17,685 | $15,131 | $12,579 | $12,546 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,426 | 5,746 | 7,326 | 8,608 | 9,890 |
| Other Non-Current Liabilities | 6,668 | 6,336 | 6,365 | 6,394 | 6,418 |
| TOTAL | $11,094 | $12,082 | $13,691 | $15,002 | $16,308 |
| Total Liabilities | $29,424 | $29,767 | $28,822 | $27,581 | $28,854 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,394 | 5,376 | 4,134 | 3,955 | 3,918 |
| Common Shares | 81 | 64 | 61 | 59 | 59 |
| Retained earnings | -281,461 | -264,129 | -247,322 | -232,295 | -218,522 |
| Other shareholders' equity | 2,689 | 2,745 | 2,775 | 2,722 | 2,762 |
| TOTAL | $194,941 | $95,774 | $91,015 | $94,548 | $107,886 |
| Total Liabilities And Equity | $224,365 | $125,541 | $119,837 | $122,129 | $136,740 |